| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 32 | 2022 | 450 | 6.530 |
Why?
|
| Heart Defects, Congenital | 33 | 2022 | 596 | 5.460 |
Why?
|
| Cardiopulmonary Bypass | 18 | 2022 | 250 | 4.820 |
Why?
|
| Methylprednisolone | 9 | 2022 | 99 | 2.490 |
Why?
|
| Infant, Newborn | 45 | 2022 | 2455 | 2.140 |
Why?
|
| Anti-Inflammatory Agents | 6 | 2019 | 234 | 1.700 |
Why?
|
| Hypoplastic Left Heart Syndrome | 10 | 2016 | 138 | 1.680 |
Why?
|
| Postoperative Complications | 15 | 2022 | 1615 | 1.530 |
Why?
|
| Glucocorticoids | 6 | 2019 | 222 | 1.480 |
Why?
|
| Inflammation | 4 | 2020 | 1030 | 1.400 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2021 | 50 | 1.330 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2020 | 186 | 1.140 |
Why?
|
| Heart Ventricles | 9 | 2014 | 738 | 1.090 |
Why?
|
| Perioperative Care | 3 | 2016 | 100 | 1.060 |
Why?
|
| Infant | 28 | 2022 | 2891 | 1.050 |
Why?
|
| Acute Kidney Injury | 3 | 2022 | 232 | 1.030 |
Why?
|
| Cardiac Output, Low | 3 | 2015 | 52 | 1.010 |
Why?
|
| Preoperative Care | 8 | 2017 | 275 | 1.000 |
Why?
|
| Norwood Procedures | 5 | 2019 | 61 | 0.990 |
Why?
|
| Pulmonary Artery | 5 | 2013 | 323 | 0.970 |
Why?
|
| Airway Extubation | 4 | 2021 | 17 | 0.960 |
Why?
|
| Hydrocortisone | 2 | 2016 | 291 | 0.960 |
Why?
|
| Treatment Outcome | 30 | 2022 | 7029 | 0.820 |
Why?
|
| Humans | 77 | 2022 | 68618 | 0.790 |
Why?
|
| Child Development | 2 | 2019 | 102 | 0.780 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 119 | 0.780 |
Why?
|
| Interdisciplinary Placement | 1 | 2021 | 6 | 0.760 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 244 | 0.750 |
Why?
|
| Fontan Procedure | 5 | 2022 | 129 | 0.740 |
Why?
|
| Prospective Studies | 18 | 2022 | 3705 | 0.740 |
Why?
|
| Length of Stay | 14 | 2020 | 780 | 0.740 |
Why?
|
| Cyclohexanones | 1 | 2020 | 9 | 0.720 |
Why?
|
| Lipocalin-2 | 1 | 2019 | 19 | 0.690 |
Why?
|
| Research Design | 5 | 2020 | 729 | 0.680 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 92 | 0.640 |
Why?
|
| Cytokines | 3 | 2013 | 866 | 0.630 |
Why?
|
| Brain Injuries | 1 | 2021 | 268 | 0.600 |
Why?
|
| Hospital Mortality | 10 | 2021 | 384 | 0.590 |
Why?
|
| Intensive Care Units, Pediatric | 5 | 2020 | 101 | 0.580 |
Why?
|
| Endpoint Determination | 2 | 2018 | 82 | 0.580 |
Why?
|
| Child | 21 | 2022 | 6405 | 0.570 |
Why?
|
| Gestational Age | 5 | 2020 | 389 | 0.550 |
Why?
|
| Anastomosis, Surgical | 5 | 2013 | 104 | 0.550 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2016 | 6 | 0.550 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2016 | 36 | 0.540 |
Why?
|
| Acidosis | 1 | 2016 | 31 | 0.530 |
Why?
|
| Female | 40 | 2021 | 38074 | 0.520 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2016 | 56 | 0.510 |
Why?
|
| Time Factors | 14 | 2020 | 4655 | 0.510 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2020 | 931 | 0.500 |
Why?
|
| Hypothermia, Induced | 1 | 2016 | 93 | 0.500 |
Why?
|
| Myocardial Contraction | 2 | 2017 | 383 | 0.490 |
Why?
|
| Male | 38 | 2021 | 37321 | 0.490 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 142 | 0.490 |
Why?
|
| Water | 1 | 2016 | 230 | 0.480 |
Why?
|
| Heart Arrest | 3 | 2022 | 113 | 0.480 |
Why?
|
| Enteral Nutrition | 4 | 2022 | 157 | 0.460 |
Why?
|
| Ventricular Function, Left | 4 | 2022 | 481 | 0.450 |
Why?
|
| Registries | 6 | 2019 | 733 | 0.450 |
Why?
|
| Steroids | 1 | 2014 | 84 | 0.450 |
Why?
|
| Biomarkers | 6 | 2021 | 1593 | 0.440 |
Why?
|
| Respiration, Artificial | 5 | 2019 | 190 | 0.430 |
Why?
|
| Child, Preschool | 13 | 2020 | 3187 | 0.420 |
Why?
|
| Retrospective Studies | 17 | 2021 | 7277 | 0.400 |
Why?
|
| Prognosis | 5 | 2021 | 2093 | 0.390 |
Why?
|
| Aprotinin | 1 | 2011 | 55 | 0.390 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2016 | 72 | 0.390 |
Why?
|
| Tranexamic Acid | 1 | 2011 | 37 | 0.390 |
Why?
|
| Cardiovascular Agents | 2 | 2018 | 82 | 0.390 |
Why?
|
| Postoperative Hemorrhage | 1 | 2011 | 69 | 0.390 |
Why?
|
| Antifibrinolytic Agents | 1 | 2011 | 52 | 0.380 |
Why?
|
| Blood Loss, Surgical | 1 | 2011 | 79 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2016 | 17 | 0.370 |
Why?
|
| Trisomy | 2 | 2016 | 47 | 0.370 |
Why?
|
| Risk Factors | 14 | 2021 | 5731 | 0.360 |
Why?
|
| Miniaturization | 1 | 2010 | 21 | 0.360 |
Why?
|
| Double-Blind Method | 6 | 2019 | 1738 | 0.350 |
Why?
|
| Incidence | 6 | 2021 | 1603 | 0.340 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2010 | 100 | 0.340 |
Why?
|
| Age Factors | 7 | 2019 | 1864 | 0.310 |
Why?
|
| Vitamin D | 1 | 2012 | 516 | 0.310 |
Why?
|
| Palliative Care | 2 | 2007 | 271 | 0.300 |
Why?
|
| Premedication | 1 | 2007 | 49 | 0.300 |
Why?
|
| Thoracic Surgery | 2 | 2020 | 72 | 0.300 |
Why?
|
| Tetralogy of Fallot | 1 | 2007 | 43 | 0.300 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2007 | 36 | 0.300 |
Why?
|
| Propranolol | 1 | 2007 | 103 | 0.300 |
Why?
|
| Creatinine | 2 | 2019 | 243 | 0.290 |
Why?
|
| Cerebral Palsy | 1 | 2007 | 24 | 0.290 |
Why?
|
| Cardiology | 2 | 2019 | 140 | 0.280 |
Why?
|
| Vasculitis | 2 | 1998 | 33 | 0.280 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 189 | 0.280 |
Why?
|
| Retinal Diseases | 2 | 1998 | 40 | 0.280 |
Why?
|
| Coronary Thrombosis | 1 | 2006 | 45 | 0.280 |
Why?
|
| Heart Aneurysm | 1 | 2006 | 21 | 0.270 |
Why?
|
| Infant, Premature, Diseases | 1 | 2007 | 85 | 0.270 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2006 | 47 | 0.260 |
Why?
|
| Hospital Costs | 2 | 2019 | 117 | 0.260 |
Why?
|
| Pediatrics | 3 | 2019 | 341 | 0.260 |
Why?
|
| Aneurysm, False | 1 | 2006 | 60 | 0.260 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2007 | 277 | 0.250 |
Why?
|
| Prostheses and Implants | 1 | 2006 | 159 | 0.250 |
Why?
|
| Blood-Aqueous Barrier | 1 | 2004 | 1 | 0.250 |
Why?
|
| Drug Administration Schedule | 4 | 2019 | 567 | 0.240 |
Why?
|
| Prednisolone | 1 | 2004 | 23 | 0.240 |
Why?
|
| Uveitis | 1 | 2004 | 13 | 0.240 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2006 | 186 | 0.240 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2006 | 164 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2019 | 1745 | 0.240 |
Why?
|
| Aortic Valve | 1 | 2006 | 249 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2004 | 18 | 0.240 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2016 | 113 | 0.230 |
Why?
|
| Phacoemulsification | 1 | 2004 | 69 | 0.230 |
Why?
|
| Injections, Intravenous | 2 | 2019 | 215 | 0.220 |
Why?
|
| Catheter-Related Infections | 2 | 2020 | 43 | 0.210 |
Why?
|
| Cohort Studies | 5 | 2021 | 2358 | 0.210 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2012 | 20 | 0.210 |
Why?
|
| United States | 7 | 2021 | 7367 | 0.210 |
Why?
|
| Enterocolitis, Necrotizing | 3 | 2017 | 37 | 0.200 |
Why?
|
| Postoperative Care | 3 | 2019 | 163 | 0.200 |
Why?
|
| Intensive Care Units | 3 | 2021 | 344 | 0.200 |
Why?
|
| Heart Failure | 2 | 2022 | 1180 | 0.200 |
Why?
|
| Fetal Hypoxia | 1 | 2001 | 5 | 0.190 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2001 | 16 | 0.190 |
Why?
|
| Echocardiography | 4 | 2021 | 515 | 0.190 |
Why?
|
| Hospital Rapid Response Team | 1 | 2021 | 9 | 0.190 |
Why?
|
| Infant Mortality | 3 | 2016 | 59 | 0.190 |
Why?
|
| Infant, Premature | 3 | 2017 | 284 | 0.180 |
Why?
|
| Central Venous Catheters | 1 | 2020 | 19 | 0.180 |
Why?
|
| Risk Assessment | 7 | 2017 | 2007 | 0.180 |
Why?
|
| Heart Bypass, Right | 2 | 2012 | 30 | 0.180 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 1465 | 0.180 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2019 | 34 | 0.170 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 89 | 0.170 |
Why?
|
| Intraoperative Period | 1 | 2019 | 62 | 0.170 |
Why?
|
| Triiodothyronine | 1 | 2019 | 22 | 0.170 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 20 | 0.170 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 3259 | 0.170 |
Why?
|
| Surgical Wound Infection | 2 | 2018 | 168 | 0.170 |
Why?
|
| Child Language | 1 | 2019 | 5 | 0.170 |
Why?
|
| Hypothyroidism | 1 | 2019 | 24 | 0.170 |
Why?
|
| Infant Behavior | 1 | 2019 | 12 | 0.160 |
Why?
|
| Patient Selection | 3 | 2018 | 592 | 0.160 |
Why?
|
| Up-Regulation | 2 | 2019 | 682 | 0.160 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 94 | 0.160 |
Why?
|
| Birth Weight | 1 | 2019 | 186 | 0.160 |
Why?
|
| Azathioprine | 1 | 1998 | 16 | 0.150 |
Why?
|
| North America | 5 | 2018 | 112 | 0.150 |
Why?
|
| Environmental Exposure | 1 | 2020 | 269 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2020 | 276 | 0.150 |
Why?
|
| Coronary Disease | 1 | 2019 | 358 | 0.150 |
Why?
|
| Retinal Vessels | 1 | 1998 | 74 | 0.150 |
Why?
|
| Ventricular Function | 3 | 2012 | 93 | 0.140 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2017 | 38 | 0.140 |
Why?
|
| Postoperative Period | 2 | 2021 | 238 | 0.140 |
Why?
|
| Milk, Human | 2 | 2016 | 147 | 0.140 |
Why?
|
| Odds Ratio | 2 | 2016 | 880 | 0.140 |
Why?
|
| Vasoconstrictor Agents | 1 | 2017 | 107 | 0.140 |
Why?
|
| Clinical Trials as Topic | 2 | 2018 | 848 | 0.140 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2016 | 106 | 0.140 |
Why?
|
| Infection Control | 1 | 2017 | 101 | 0.140 |
Why?
|
| Cross Infection | 1 | 2018 | 195 | 0.140 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 99 | 0.140 |
Why?
|
| Intensive Care, Neonatal | 1 | 2016 | 38 | 0.140 |
Why?
|
| Chylothorax | 1 | 2016 | 11 | 0.140 |
Why?
|
| Cardiac Care Facilities | 1 | 2015 | 3 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 442 | 0.130 |
Why?
|
| Program Evaluation | 1 | 2018 | 502 | 0.130 |
Why?
|
| South Carolina | 2 | 2013 | 2752 | 0.130 |
Why?
|
| Chorioamnionitis | 1 | 2016 | 40 | 0.130 |
Why?
|
| Fetal Blood | 1 | 2016 | 131 | 0.130 |
Why?
|
| Motor Activity | 1 | 2019 | 621 | 0.130 |
Why?
|
| RNA, Nuclear | 1 | 2015 | 1 | 0.130 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2015 | 6 | 0.130 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2015 | 5 | 0.130 |
Why?
|
| Lactulose | 1 | 2015 | 13 | 0.130 |
Why?
|
| Mannitol | 1 | 2015 | 25 | 0.130 |
Why?
|
| Infant Formula | 1 | 2015 | 24 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 24 | 0.130 |
Why?
|
| Vision Disorders | 1 | 1996 | 94 | 0.130 |
Why?
|
| Placenta | 1 | 2016 | 101 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 378 | 0.130 |
Why?
|
| Professional Role | 1 | 2015 | 80 | 0.120 |
Why?
|
| Ambulatory Care | 1 | 2017 | 340 | 0.120 |
Why?
|
| Interleukin-6 | 2 | 2019 | 330 | 0.120 |
Why?
|
| Cornea | 1 | 2015 | 76 | 0.120 |
Why?
|
| Cognition | 1 | 2019 | 513 | 0.120 |
Why?
|
| Visual Acuity | 3 | 2004 | 236 | 0.120 |
Why?
|
| Thrombin | 1 | 2015 | 117 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2018 | 310 | 0.120 |
Why?
|
| Linear Models | 2 | 2013 | 521 | 0.120 |
Why?
|
| Pregnancy | 2 | 2016 | 2334 | 0.120 |
Why?
|
| Ischemia | 1 | 1996 | 229 | 0.120 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 177 | 0.120 |
Why?
|
| Nervous System | 1 | 2014 | 45 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 191 | 0.120 |
Why?
|
| Leadership | 1 | 2015 | 136 | 0.120 |
Why?
|
| Diastole | 2 | 2022 | 161 | 0.120 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 219 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2016 | 403 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 514 | 0.120 |
Why?
|
| Arteriovenous Malformations | 1 | 2013 | 34 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 546 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2015 | 311 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2015 | 1040 | 0.110 |
Why?
|
| Cardiac Output | 1 | 2013 | 133 | 0.110 |
Why?
|
| Depression | 1 | 2019 | 943 | 0.100 |
Why?
|
| Cell Movement | 1 | 2015 | 630 | 0.100 |
Why?
|
| Factor VIIa | 1 | 2011 | 25 | 0.100 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 112 | 0.100 |
Why?
|
| Platelet Transfusion | 1 | 2011 | 21 | 0.100 |
Why?
|
| Thoracic Arteries | 1 | 2011 | 10 | 0.100 |
Why?
|
| Hospital Charges | 1 | 2011 | 60 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 493 | 0.100 |
Why?
|
| Survival Rate | 2 | 2021 | 1056 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 371 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 786 | 0.100 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 72 | 0.100 |
Why?
|
| Canada | 2 | 2019 | 267 | 0.100 |
Why?
|
| Interleukin-2 | 1 | 2011 | 133 | 0.090 |
Why?
|
| Heart | 1 | 2016 | 850 | 0.090 |
Why?
|
| Renin-Angiotensin System | 1 | 2011 | 79 | 0.090 |
Why?
|
| Intraoperative Care | 1 | 2011 | 91 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2015 | 753 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 940 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2015 | 657 | 0.090 |
Why?
|
| Heart Septal Defects | 1 | 2010 | 27 | 0.090 |
Why?
|
| Brain | 1 | 2001 | 2176 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2013 | 384 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2015 | 902 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 1 | 2010 | 84 | 0.090 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 292 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 742 | 0.090 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 1046 | 0.080 |
Why?
|
| Embolization, Therapeutic | 1 | 2011 | 150 | 0.080 |
Why?
|
| Reoperation | 2 | 2012 | 467 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 626 | 0.080 |
Why?
|
| Equipment Design | 1 | 2010 | 500 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 223 | 0.080 |
Why?
|
| Cardiac Catheterization | 2 | 2011 | 419 | 0.080 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 318 | 0.080 |
Why?
|
| Prevalence | 1 | 2012 | 1619 | 0.080 |
Why?
|
| Quality of Life | 1 | 2016 | 1515 | 0.080 |
Why?
|
| Cardiotonic Agents | 1 | 2007 | 71 | 0.070 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2007 | 33 | 0.070 |
Why?
|
| Adolescent | 5 | 2018 | 8912 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2007 | 122 | 0.070 |
Why?
|
| Systole | 1 | 2007 | 149 | 0.070 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2007 | 69 | 0.070 |
Why?
|
| Myocardium | 1 | 2012 | 1204 | 0.070 |
Why?
|
| Ventricular Pressure | 1 | 2007 | 82 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2007 | 123 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2007 | 714 | 0.070 |
Why?
|
| Heart Atria | 1 | 2006 | 206 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2006 | 242 | 0.060 |
Why?
|
| Heart Rate | 1 | 2007 | 568 | 0.060 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2006 | 117 | 0.060 |
Why?
|
| Thrombosis | 1 | 2006 | 218 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2006 | 291 | 0.060 |
Why?
|
| Aorta | 1 | 2006 | 316 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2007 | 601 | 0.060 |
Why?
|
| Middle Aged | 6 | 2019 | 21147 | 0.060 |
Why?
|
| Macular Edema | 1 | 2004 | 21 | 0.060 |
Why?
|
| Heart Valve Prosthesis | 1 | 2006 | 222 | 0.060 |
Why?
|
| Recurrence | 2 | 1998 | 948 | 0.060 |
Why?
|
| Thrombectomy | 1 | 2006 | 238 | 0.060 |
Why?
|
| Europe | 1 | 2004 | 196 | 0.060 |
Why?
|
| Hemodynamics | 3 | 2012 | 705 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2004 | 411 | 0.060 |
Why?
|
| Disease Management | 1 | 2005 | 248 | 0.060 |
Why?
|
| Nutritional Support | 1 | 2022 | 22 | 0.050 |
Why?
|
| Parenteral Nutrition | 1 | 2022 | 39 | 0.050 |
Why?
|
| Nutritional Requirements | 1 | 2022 | 57 | 0.050 |
Why?
|
| Adult | 4 | 2019 | 21403 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2022 | 112 | 0.050 |
Why?
|
| Calcium Chloride | 1 | 2021 | 38 | 0.050 |
Why?
|
| Uridine Triphosphate | 1 | 2001 | 4 | 0.050 |
Why?
|
| RNA Polymerase I | 1 | 2001 | 5 | 0.050 |
Why?
|
| Amanitins | 1 | 2001 | 2 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 1851 | 0.050 |
Why?
|
| RNA Polymerase III | 1 | 2001 | 7 | 0.050 |
Why?
|
| RNA Polymerase II | 1 | 2001 | 14 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 807 | 0.050 |
Why?
|
| Tritium | 1 | 2001 | 101 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2001 | 124 | 0.050 |
Why?
|
| Critical Illness | 1 | 2022 | 191 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 2279 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2012 | 536 | 0.050 |
Why?
|
| Genotype | 2 | 2015 | 786 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2077 | 0.050 |
Why?
|
| Logistic Models | 2 | 2016 | 1420 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 306 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 792 | 0.040 |
Why?
|
| Quebec | 1 | 2019 | 2 | 0.040 |
Why?
|
| Patient Health Questionnaire | 1 | 2019 | 9 | 0.040 |
Why?
|
| Placebos | 1 | 2019 | 195 | 0.040 |
Why?
|
| Insulin | 1 | 2022 | 619 | 0.040 |
Why?
|
| Inpatients | 1 | 2021 | 208 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 586 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2019 | 144 | 0.040 |
Why?
|
| Academic Success | 1 | 2018 | 5 | 0.040 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2018 | 31 | 0.040 |
Why?
|
| Awards and Prizes | 1 | 2018 | 27 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 2223 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 17 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2019 | 158 | 0.040 |
Why?
|
| Critical Care | 1 | 2020 | 263 | 0.040 |
Why?
|
| Urinary Tract Infections | 1 | 2018 | 71 | 0.040 |
Why?
|
| Mentors | 1 | 2018 | 81 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 186 | 0.040 |
Why?
|
| Aged | 3 | 2019 | 14862 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2018 | 82 | 0.040 |
Why?
|
| Catheterization | 1 | 2018 | 209 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 124 | 0.040 |
Why?
|
| Ligation | 1 | 2017 | 83 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 211 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2018 | 186 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 109 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2016 | 46 | 0.030 |
Why?
|
| Feeding Methods | 1 | 2015 | 17 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1998 | 649 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 136 | 0.030 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 37 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 506 | 0.030 |
Why?
|
| Triglycerides | 1 | 2016 | 184 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 981 | 0.030 |
Why?
|
| Transcription Factor 4 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Transposition of Great Vessels | 1 | 2015 | 51 | 0.030 |
Why?
|
| Fibrin | 1 | 2015 | 35 | 0.030 |
Why?
|
| Endothelium, Corneal | 1 | 2015 | 20 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 85 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2015 | 32 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 131 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 144 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 652 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 498 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 368 | 0.030 |
Why?
|
| Algorithms | 1 | 2019 | 1196 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 622 | 0.030 |
Why?
|
| Primary Health Care | 1 | 1999 | 703 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 333 | 0.030 |
Why?
|
| Mass Screening | 1 | 1999 | 843 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 1999 | 778 | 0.030 |
Why?
|
| Chest Tubes | 1 | 2012 | 18 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 168 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 659 | 0.020 |
Why?
|
| Collagen | 1 | 2015 | 636 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 672 | 0.020 |
Why?
|
| Pleural Effusion | 1 | 2012 | 74 | 0.020 |
Why?
|
| Cause of Death | 1 | 2012 | 241 | 0.020 |
Why?
|
| Angiotensins | 1 | 2011 | 16 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 349 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 2011 | 34 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2011 | 21 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2011 | 38 | 0.020 |
Why?
|
| Aldosterone | 1 | 2011 | 51 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 114 | 0.020 |
Why?
|
| Renin | 1 | 2011 | 96 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2800 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 1342 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 947 | 0.020 |
Why?
|
| Animals | 2 | 2013 | 20881 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 301 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 238 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2673 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2012 | 328 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2007 | 53 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 5717 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2007 | 133 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2550 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 4848 | 0.020 |
Why?
|
| Oxygen | 1 | 2006 | 386 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2007 | 448 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 1999 | 425 | 0.010 |
Why?
|
| Attitude to Health | 1 | 1999 | 403 | 0.010 |
Why?
|
| Learning | 1 | 1975 | 186 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 1975 | 214 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1975 | 596 | 0.010 |
Why?
|
| Community Medicine | 1 | 1975 | 8 | 0.000 |
Why?
|
| Hospitals, Community | 1 | 1975 | 64 | 0.000 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1975 | 60 | 0.000 |
Why?
|
| Hospitals, University | 1 | 1975 | 169 | 0.000 |
Why?
|
| Physical Examination | 1 | 1975 | 152 | 0.000 |
Why?
|
| Demography | 1 | 1975 | 279 | 0.000 |
Why?
|
| Hospitals, Pediatric | 1 | 1975 | 114 | 0.000 |
Why?
|
| Teaching | 1 | 1975 | 169 | 0.000 |
Why?
|
| Physician-Patient Relations | 1 | 1975 | 261 | 0.000 |
Why?
|